DADC
LABU icon

D.A. Davidson & Co’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

D.A. Davidson & Co’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-19
Closed -$10K – 2356
2016
Q1 		$10K Buy
19
+16
+533% +$10.1K ﹤0.01% 1905
2015
Q4 		$4K Hold
3
– – ﹤0.01% 2052
2015
Q3 		$3K Buy
+3
New +$9.16K ﹤0.01% 2067

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.A. Davidson & Co's LABU Position: Q2 2016 in Review

D.A. Davidson & Co sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2016, closing a stake of 19 shares — an estimated $10K sold.

D.A. Davidson & Co first reported a position in LABU in Q3 2015 and held it in 3 quarters. The position peaked at $10K in Q1 2016. 19 funds tracked by Wall St. Rank hold LABU as of Q2 2016.

  • D.A. Davidson & Co reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2016 after selling out during the quarter.
  • D.A. Davidson & Co sold 19 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2016, an estimated $10K.
  • D.A. Davidson & Co first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and held it in 3 quarters.
  • D.A. Davidson & Co's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $10K in Q1 2016.
  • 19 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2016.

Based on D.A. Davidson & Co's 13F filing for Q2 2016, filed 15 Aug 2016.